Follicular lymphoma grade 3B: low grade, high grade or should we skip the grade?

por Mulvey, Erin, Leonard, John P.
Publicado 2023

Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin’s lymphoma

por Andemariam, Biree, Leonard, John P
Publicado 2007

Effects of sun angle, lunar illumination, and diurnal temperature on temporal movement rates of sympatric ocelots and bobcats in South Texas

por Leonard, John P., Tewes, Michael E., Lombardi, Jason V., Wester, David W., Campbell, Tyler A.
Publicado 2020

An architecture for research computing in health to support clinical and translational investigators with electronic patient data

por Campion, Thomas R, Sholle, Evan T, Pathak, Jyotishman, Johnson, Stephen B, Leonard, John P, Cole, Curtis L
Publicado 2021

Induction of prolonged early G(1) arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1

por Chiron, David, Martin, Peter, Di Liberto, Maurizio, Huang, Xiangao, Ely, Scott, Lannutti, Brian J., Leonard, John P., Mason, Christopher E., Chen-Kiang, Selina
Publicado 2013

Human iPSC-derived astrocytes generated from donors with globoid cell leukodystrophy display phenotypes associated with disease

por Lieberman, Richard, Cortes, Leslie K., Gao, Grace, Park, Hyejung, Wang, Bing, Jones, Patrick L., Hunter, R. Bridge, Leonard, John P., Barker, Robert H.
Publicado 2022

The feasibility, acceptability, and usability of telehealth visits

por Sinha Gregory, Naina, Shukla, Alpana P., Noel, Jahi J., Alonso, Laura C., Moxley, Jerad, Crawford, Andrew J., Martin, Peter, Kumar, Sonal, Leonard, John P., Czaja, Sara J.
Publicado 2023

Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma

por Yamshon, Samuel, Chen, Gui Zhen, Gribbin, Caitlin, Christos, Paul, Shah, Bijal, Schuster, Stephen J., Smith, Sonali M., Svoboda, Jakub, Furman, Richard R., Leonard, John P., Martin, Peter, Ruan, Jia
Publicado 2023

CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease

por Marshall, John, Sun, Ying, Bangari, Dinesh S, Budman, Eva, Park, Hyejung, Nietupski, Jennifer B, Allaire, Amy, Cromwell, Mary A, Wang, Bing, Grabowski, Gregory A, Leonard, John P, Cheng, Seng H
Publicado 2016

Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease

por Natoli, Thomas A., Husson, Hervé, Rogers, Kelly A., Smith, Laurie A., Wang, Bing, Budman, Yeva, Bukanov, Nikolay O., Ledbetter, Steven R., Klinger, Katherine W., Leonard, John P., Ibraghimov-Beskrovnaya, Oxana
Publicado 2012

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials

por Lansigan, Frederick, Barak, Ian, Pitcher, Brandelyn, Jung, Sin‐Ho, Cheson, Bruce D., Czuczman, Myron, Martin, Peter, Hsi, Eric, Schöder, Heiko, Smith, Scott, Bartlett, Nancy L., Leonard, John P., Blum, Kristie A.
Publicado 2018

Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001

por Stephens, Deborah M., Li, Hongli, Constine, Louis S., Fitzgerald, Thomas J., Leonard, John P., Kahl, Brad S., Song, Joo Y., LeBlanc, Michael L., Smith, Sonali M., Persky, Daniel O., Friedberg, Jonathan W.
Publicado 2022

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma

por Burack, W. Richard, Li, Hongli, Adlowitz, Diana, Spence, Janice M., Rimsza, Lisa M., Shadman, Mazyar, Spier, Catherine M., Kaminski, Mark S., Leonard, John P., Leblanc, Michael L., Smith, Sonali M., Friedberg, Jonathan W.
Publicado 2023

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL

por Martin, Peter, Bartlett, Nancy L., Chavez, Julio C., Reagan, John L., Smith, Sonali M., LaCasce, Ann S., Jones, Jeffrey, Drew, James, Wu, Chengqing, Mulvey, Erin, Revuelta, Maria V., Cerchietti, Leandro, Leonard, John P.
Publicado 2022

Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis

por Torka, Pallawi, Pederson, Levi D., Knopp, Michael V., Poon, David, Zhang, Jun, Kahl, Brad S., Higley, Howard R., Kelloff, Gary, Friedberg, Jonathan W., Schwartz, Lawrence H., Wilson, Wyndham H., Leonard, John P., Bartlett, Nancy L., Schöder, Heiko, Ruppert, Amy S.
Publicado 2023

Cytosolic phospholipase A(2)α–deficient mice are resistant to experimental autoimmune encephalomyelitis

por Marusic, Suzana, Leach, Michael W., Pelker, Jeffrey W., Azoitei, Mihai L., Uozumi, Naonori, Cui, Junqing, Shen, Marina W.H., DeClercq, Charlene M., Miyashiro, Joy S., Carito, Brenda A., Thakker, Paresh, Simmons, David L., Leonard, John P., Shimizu, Takao, Clark, James D.
Publicado 2005

Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy

por Jacobs, Samantha E., Lamson, Daryl M., Soave, Rosemary, Guzman, Brigitte Huertas, Shore, Tsiporah B., Ritchie, Ellen K., Zappetti, Dana, Satlin, Michael J., Leonard, John P., Besien, Koen van, Schuetz, Audrey N., Jenkins, Stephen G., George, Kirsten St., Walsh, Thomas J.
Publicado 2015

A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology

por Birket, Matthew J., Raibaud, Sophie, Lettieri, Miriam, Adamson, Antony D., Letang, Valerie, Cervello, Pauline, Redon, Nicolas, Ret, Gwenaelle, Viale, Sandra, Wang, Bing, Biton, Bruno, Guillemot, Jean-Claude, Mikol, Vincent, Leonard, John P., Hanley, Neil A., Orsini, Cecile, Itier, Jean-Michel
Publicado 2019

Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

por Coutre, Steven E., Flinn, Ian W., de Vos, Sven, Barrientos, Jacqueline C., Schreeder, Marshall T., Wagner-Johnson, Nina D., Sharman, Jeff P., Boyd, Thomas E., Fowler, Nathan, Dreiling, Lyndah, Kim, Yeonhee, Mitra, Siddhartha, Rai, Kanti, Leonard, John P., Furman, Richard R.
Publicado 2018

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

por Leonard, John P., Trneny, Marek, Izutsu, Koji, Fowler, Nathan H., Hong, Xiaonan, Zhu, Jun, Zhang, Huilai, Offner, Fritz, Scheliga, Adriana, Nowakowski, Grzegorz S., Pinto, Antonio, Re, Francesca, Fogliatto, Laura Maria, Scheinberg, Phillip, Flinn, Ian W., Moreira, Claudia, Cabeçadas, José, Liu, David, Kalambakas, Stacey, Fustier, Pierre, Wu, Chengqing, Gribben, John G.
Publicado 2019